The AlphaLISA™ Human C1q Binding Kit is designed to monitor the binding of the IgG Fc region to the human C1q protein.
Feature | Specification |
---|---|
Application | Protein-Protein Interaction |
Sample Volume | 5 µL |
The AlphaLISA™ Human C1q Binding Kit is designed to monitor the binding of the IgG Fc region to the human C1q protein.
Complement component 1q, also known as C1q, is a protein complex involved in the complement system. C1q senses antigen/antibody complexes formed with IgG or IgM and binds to antibody Fc via its globular heads. When this occurs, intramolecular rearrangement of the C1 complex is induced, triggering the activation of C1r and C1s proteases and the sequential cleavage of the circulating complement proteins. This leads to the formation of the Membrane Attack Complex (MAC) and to cell lysis. C1q binding measurements are related to the mechanism of action and Fc effector functions of biologics and therapeutic antibodies and utilized for studies in oncology, autoimmune disease, neurology, and infectious disease.
Application |
Protein-Protein Interaction
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Modality |
Alpha
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
C1q
|
Target Class |
Binding Assay
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
Cardiovascular
Immuno-oncology
Infectious Disease (non-viral)
Inflammation
Metabolic
Neuroscience
Oncology
Rare Diseases
Respiratory
Virology
|
Unit Size |
100 assay points
|
Loading...
We are here to answer your questions.